BD to acquire Bard for $24 billion
BD (Becton, Dickinson and Company) announced a definitive agreement to acquire C. R. Bard, Inc. for $317.00 per share in cash and stock, total consideration $24 billion. The transaction is expected to be immediately accretive and generate cost synergies.
Productsmedication management, infection prevention, vascular, urology, oncology, surgical specialty products
“BD (Becton, Dickinson and Company) and C. R. Bard, Inc. announced today a definitive agreement under which BD will acquire Bard for $317.00 per Bard common share in cash and stock, for a total consideration of $24 billion.”news.bd.com
- 5 sources
- news.bd.comBD Newsroom - Press releasesApr 23, 2017
- investors.bd.comApril 24, 2017 - EX-99.3 - 8-K: Current report filing | Becton, Dickinson and Company (BDX)Apr 24, 2017
- investors.bd.comBD To Acquire Bard For $24 Billion :: Becton, Dickinson and Company (BDX)Apr 24, 2017
- postandcourier.comOwner of Moncks Corner medical device plant being soldJohn McDermottApr 24, 2017
- jdsupra.comBecton Dickinson to Acquire C. R. Bard for $24 Billion | Knobbe Martens - JDSupraMay 3, 2017
Summarized from public sources; check the original articles before acting on it.
ENDATA